HS
ROIV icon

HighVista Strategies’s Roivant Sciences ROIV Stock Holding History

HighVista Strategies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-98,858
Closed -$1.5M – 172
2025
Q3 		$1.5M Buy
98,858
+37,590
+61% +$465K 0.37% 82
2025
Q2 		$690K Sell
61,268
-54,058
-47% -$586K 0.25% 117
2025
Q1 		$1.16M Hold
115,326
– – 0.45% 101
2024
Q4 		$1.36M Hold
115,326
– – 0.51% 81
2024
Q3 		$1.33M Sell
115,326
-11,415
-9% -$130K 0.46% 89
2024
Q2 		$1.34M Sell
126,741
-85,377
-40% -$936K 0.49% 79
2024
Q1 		$2.24M Buy
212,118
+157,188
+286% +$1.69M 0.8% 42
2023
Q4 		$617K Buy
+54,930
New +$535K 0.22% 111

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HighVista Strategies's ROIV Position: Q4 2025 in Review

HighVista Strategies sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 98,858 shares — an estimated $1.5M sold.

HighVista Strategies first reported a position in ROIV in Q4 2023 and held it in 8 quarters. The position peaked at $2.24M in Q1 2024. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • HighVista Strategies reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • HighVista Strategies sold 98,858 Roivant Sciences shares in Q4 2025, an estimated $1.5M.
  • HighVista Strategies first reported a position in Roivant Sciences in Q4 2023 and held it in 8 quarters.
  • HighVista Strategies's Roivant Sciences position peaked at $2.24M in Q1 2024.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on HighVista Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.